Shaoling Li
6Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: Jun 28, 2003 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9066870B2 | Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles | Human Necessities | 2 | Active |
| US11220501B2 | Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US7338663B2 | Expandable osmotic composition and coating suspension | Human Necessities | 1 | Expired |
| US10369142B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 1 | Active |
| US11452723B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 0 | Active |
| US10946009B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.